Recent News for ODT - Odonate Therapeutics, Inc.

Date Title
Apr 2 PLAY, GME and ADXS among after hours movers
Apr 2 Tesetaxel Brain Concentrations Exceeded Concentrations Required for Tumor Killing for Sustained Period of Time in Preclinical Testing
Mar 28 Odonate Therapeutics Initiates CONTESSA TRIO
Mar 22 Key events next week - healthcare
Mar 17 Weekly CEO Buys Highlight
Mar 14 Have Insiders Been Buying Odonate Therapeutics, Inc. (NASDAQ:ODT) Shares?
Mar 11 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $2.6 million of Shares
Mar 6 Odonate Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference
Mar 4 Odonate launches mid-stage study of tesetaxel in breast cancer
Mar 4 Odonate Therapeutics Announces Initiation of CONTESSA 2, a Phase 2 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received a Taxane
Feb 28 Odonate Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2019
Feb 22 Odonate Therapeutics misses by $0.07
Feb 22 Odonate files for $150M stock offering
Feb 22 Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018
Feb 22 Detailed Research: Economic Perspectives on Omnicom Group, Venator Materials, Leidos, International Flavors & Fragrances, Odonate Therapeutics, and Aqua America — What Drives Growth in Today's Competitive Landscape
Jan 7 Odonate Therapeutics: Small Biotech Firm Seeks To Improve Quality Of Life For Breast Cancer Patients
Dec 31 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $835,107 of Shares
Dec 27 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $756,000 of Shares
Dec 20 The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Dec 19 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $586,800 of Shares
Dec 14 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $312,000 of Shares
Nov 27 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $258,967 of Shares
Nov 9 Consolidated Research: 2018 Summary Expectations for Senior Housing Properties Trust, NACCO Industries, Primo Water, Martin Marietta Materials, Iamgold, and Odonate Therapeutics — Fundamental Analysis, Key Performance Indications
Nov 6 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $148,700 of Shares
Nov 5 74 Biggest Movers From Friday

Back to the Main ODT Page...